Assignee
CALIWAY BIOPHARMACEUTICALS CO LTD
TW·9 granted patents·10 pending applications·15 citations·filing 2015–2025
Top patents by PatentIndex Score
19 records- 0190US10610496B2Pharmaceutical composition for reducing local fat and uses thereofCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Apr 7, 2020·6 cites·18 claims
- 0289US12357588B2Pharmaceutical composition for reducing local fat and uses thereofCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2022·Granted Jul 15, 2025·1 cites·21 claims
- 0387US10226503B2Plant extract composition for reducing topical fat and promoting weight loss as well as applications thereofCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2017·Granted Mar 12, 2019·4 cites·20 claims
- 0481US11433034B2Pharmaceutical composition for reducing local fat and uses thereofCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2020·Granted Sep 6, 2022·1 cites·21 claims
- 0581US10537605B2Composition of plant extract and its pharmaceutical composition and application thereofCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2015·Granted Jan 21, 2020·2 cites·13 claims
- 0678US10716824B2Subcutaneous injection formulation for reducing body weight and uses thereofCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2017·Granted Jul 21, 2020·1 cites·23 claims
- 0765US2025017874A1Pharmaceutical compositions for use in reducing hyperpigmentationCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 0863US2024165050A1Method for treating and/or preventing edematous fibrosclerotic panniculopathyCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0962US10537548B2Composition and medical product for reducing body weight and body fat, and use of said productCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2018·Granted Jan 21, 2020·0 cites·33 claims
- 1062US2020230102A1Composition and medical product for reducing body weight and body fat, and use of said productCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 1161US2023190674A1Methods for Reduction of Body Weight with Subcutaneous FormulationsCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1259US2023372378A1Compositions and methods for alleviating conditions caused by abnormal subcutaneous deposit of adipose tissue or fatCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1358US2026053755A1Pharmaceutical compositions for use in treating obstructive sleep apneaCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 1458US2025154089A1Methods for preparing oxyresveratrol and derivatives thereofCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 1557US2020338152A1Subcutaneous injection formulation for reducing body weight and uses thereofCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1656US11318110B2Pharmaceutical composition for reducing local fat and uses thereofCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2020·Granted May 3, 2022·0 cites·19 claims
- 1745US2025241870A1Oxyresveratrol and derivatives thereof for use in lipolysisCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 1841US9987325B2Plant extract composition for reducing localized fat and promoting weight loss as well as application thereofCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2015·Granted Jun 5, 2018·0 cites·26 claims
- 1935US2016374911A1Plant extract composition for skin whitening and reducing melanin as well as application thereofCALIWAY BIOPHARMACEUTICALS CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CALIWAY BIOPHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →